Yüklüyor......

Randomized, multi-center trial of argatroban with recombinant tissue plasminogen activator for acute stroke (ARTSS-2)

BACKGROUND AND PURPOSE: We conducted a randomized exploratory study to assess safety and the probability of a favorable outcome with adjunctive argatroban, a direct thrombin-inhibitor, administered to rt-PA treated ischemic stroke patients. METHODS: Patients treated with standard-dose rt-PA, not rec...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Stroke
Asıl Yazarlar: Barreto, Andrew D., Ford, Gary A., Shen, Loren, Pedroza, Claudia, Tyson, Jon, Cai, Chunyan, Rahbar, Mohammad H., Grotta, James C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5499711/
https://ncbi.nlm.nih.gov/pubmed/28507269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.117.016720
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!